illumina stock forecast

Monday, November 15, 2021. The company also guided to 36% revenue growth, which would be about $4.41 billion. ET by MarketWatch Automation Illumina Inc. stock falls Tuesday, underperforms market According to 19 analysts, the average rating for Illumina stock is "Hold." The 12-month stock price forecast is 443.56, which is an increase of 15.02% from the latest price. In the short term (2weeks), ILMN's stock price should underperform the market by -0.66%.During that period the price should oscillate between -5.99% and +4.96%.. Illumina Inc Stock Forecast. Illumina generates revenue from two segments - Product and Service. ILMN has a higher market value than 95.46% of US stocks; more precisely, its current market capitalization is $57,137,028,000. Ten analysts forecast the average price in 12 months at $346.00 with a high forecast of $400.00 and a low forecast of $280.00. View analysts' price targets for Illumina or view top-rated stocks among Wall Street analysts. The average price target is $339.6, which means analysts expect the stock to add by 4.19% over the next twelve months. The 15 analysts offering 12-month price forecasts for Illumina Inc have a median target of 422.00, with a high estimate of 570.00 and a low estimate of 350.00. The P/E ratio of Illumina is 104.41, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.86. This suggests a possible upside of 15.2% from the stock's current price. Sales guidance also beat. Illumina stock forecast. And if you believe that the stock is really worth $460.71, then there's not much of an upside to gain from mispricing. Stock Target Advisor's own stock analysis of Illumina Inc is Slightly Bullish , which is based on 9 positive signals and 5 negative signals. Thursday, November 11, 2021. Illumina, Inc. is an American company. Click the image for more detail. Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease PR Newswire - PRF. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. Illumina stock traded higher Friday on price target upgrades by analysts after the gene sequencing firm reported better-than-expected fourth quarter sales and revenue. Illumina last released its earnings data on November 4th, 2021. Close price at the end of the last trading day (Wednesday, 17th Nov 2021) of the ILMN stock was $377.63. Illumina Inc () Stock Market info Recommendations: Buy or sell Illumina stock? Based on 8 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average Illumina stock price prediction forecasts a potential downside of N/A from the current ILMN share price of $379.34. However, it does not forecast the overall direction of its price. Metagenomics Sequencing Market Research Report and Forecast to 2028 - Illumina, Novogene, Gatc Biotech Get Sample Report Buy Complete Report A2Z Market Research introduce new research on Metagenomics Sequencing covering micro level of analysis by competitors and key business segments (2021-2028). The number of long hedge fund bets were trimmed by 1 in recent months. However, stock prices are usually driven by a company's financials over the long term, which in this case look . Illumina ( ILMN) specializes in manufacturing DNA sequencing equipment. The stock seems fairly valued at the moment according to my valuation model. Product revenues (84.4% of total revenues in 2020; down 6.6% from 2019) are primarily attributed to the partnerships and . Illumina stock forecast. Stock Price Forecast. 20 August 2021 - EC says Illumina-GRAIL may have breached "the standstill obligation" and "can be fined up to 10% of their annual worldwide turnover.". For the full year, revenue is expected to come in at $4.35bn, a jump of 34.4% year-on-year, although that growth rate is expected to slow to . ILLUMINA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ILLUMINA, INC. Stock | ILMN | US4523271090 ILLUMINA, INC. earnings per share revisions and analysts forecast | Nasdaq: ILMN | Nasdaq Illumina, Inc. (ILMN Quick Quote ILMN - Free Report) , in collaboration with Genetic Alliance, recently announced the establishment of the iHope Genetic Health program.This development is aimed at . BSX stock trades at about 5.6x trailing revenues, compared to around 18.8x for ILMN. In-depth view of key statistics and finances for ILLUMINA, INC. (ILMN) on MSN Money. Earnings for Illumina are expected to grow by 19.13% in the coming year, from $4.39 to $5.23 per share. ILMN : Illumina stock forecast by Wall Street Analysts. ILMN has a four bull (high rated) technical rating because the stock is trading above its 10-, 50-and 200- day moving averages and even though the stock is down on the day, the 10-day MA is above the 50-day MA (also called a "swing golden cross"). Start a 14-day free trial to Morningstar Premium to unlock our . Illumina Inc (ILMN) Stock Analysis Based on the Illumina Inc stock forecasts from 7 analysts, the average analyst target price for Illumina Inc is USD 439.63 over the next 12 months. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Illumina share forecasts, stock quote and buy / sell signals below.According to present data Illumina's ILMN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Illumina, Inc. (NASDAQ:ILMN) saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS.As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. This is a -1.29% down since the beginning of the trading day. Actively observing the price movement in the last trading, the stock closed the session at $365.56, falling w Price as of November 23, 2021, 10:52 a.m. Illumina (NASDAQ:ILMN) has had a rough three months with its share price down 22%. Illumina (ILMN) Trading Report Stock Traders Daily. The average price target is $496.86 with a high forecast of $560.00 and a low forecast of $365.00. It is clearly the world leader in the segment. As of 2021 November 27, Saturday current price of ILMN stock is 365.560$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Illumina stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. On average, analysts forecast that ILMN's EPS will be $6.48 for 2021, with the lowest . In the medium term (3months), ILMN's stock price should underperform the market by -2.11%. Get the latest Illumina detailed stock quotes, stock trade data, stock price info, and performance analysis, including Illumina Stock investment advice, charts, stats and more. Illumina Inc. stock outperforms market despite losses on the day Nov. 17, 2021 at 5:00 p.m. The best long-term & short-term ILLUMINA share price prognosis for 2021 . With a price/earnings ratio of 63.07, Illumina Inc P/E ratio is greater than that of about 86.77% of stocks in our set with positive earnings. The average price target represents a 14.72% upside from the last price of $379.34. Wall Street is positive on Illumina, Inc. . People with decade-long investment horizons don't ask why a stock fell less than five percent. Also, this average forecast of $393.0 represents a -5.3% decrease from the past average forecast of $415.0, 6 months ago from 13 wall street analysts. The average Illumina stock forecast from last 6 month is $393.0, and this show a 5.56% increase in average from the prior price target of the each prediction. Please note that any opinions, estimates or forecasts regarding Illumina's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Illumina or its management. Illumina, Inc. (NASDAQ:ILMN) saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS.As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. The current Illumina Inc [] share price is $377.15. ILMN Stock Predictions, Articles, and Illumina Inc News From InvestorPlace From the Web 5 Healthcare Stocks to Buy for Their Game-Changing Potential By Larry Ramer, InvestorPlace . Analysts expected Illumina to earn $6.29 per share. As of Feb. 15, 2021, Illumina stock has a market capitalization of $73.7 billion and trades nearly 40% higher over the past month. Illumina is followed by the analysts listed above. SAN DIEGO, Nov. 4, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2021, which include the consolidated financial results SAN DIEGO, Oct. 27, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced an agreement with Israel's Ministry of Health (MoH) for a pilot program to implement the use of whole-genome . Here are the consensus estimates for next quarter. 04:24 AM ET. In a nutshell, if Illumina's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. Stocks USA. The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. On average, analysts give Illumina, Inc. a Strong Buy rating. Their forecasts range from $335.00 to $570.00. The company develops, manufactures, and markets next-generation life-science tools and . Find the latest Illumina, Inc. (MYL) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance This is 0.23% less than the trading day before Tuesday, 16th Nov 2021. Agrigenomics Market Size 2021 with CAGR of 6.4%, Top Growth Companies: Thermo Fisher Scientific, Illumina, Agilent Technologies, and, End-User, SWOT Analysis in Industry 2026 Published: Nov. 27 . Earnings and Valuation of Illumina (NASDAQ:ILMN. 18 August 2021 - Illumina closes GRAIL acquisition. The best stock pickers were becoming less hopeful. Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. Learn about ILMN (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. This chart shows the closing price for ILMN for the . The average price target represents a 28.09% . However, it does have US$1.27b in cash offsetting this, leading to net debt of about US$422.0m. The average price target represents a 6.40% change from the last price of $466.98. As you can see below, at the end of October 2021, Illumina had US$1.69b of debt, up from US$1.17b a year ago. Quarterly revenue increased 79% to $1.13B, beating analysts . Illumina Inc (ILMN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. ILMN Stock Summary. The stock's open price was 395.36. Does . On average, they anticipate Illumina's stock price to reach $435.18 in the next year. Get the latest Illumina, Inc. (ILMN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Illumina Inc. (NASDAQ:ILMN) shares, rose in value on Friday, 11/26/21, with the stock price up by 1.16% to the previous day's close as strong demand from buyers drove the stock to $369.79. During the day the stock fluctuated 2.09% from a day low at $374.74 to a day high of $382.56. The average price target represents a 28.09% . ILMN stock forecast Our latest prediction for Illumina Inc's stock price was made on the May 4, 2021 when the stock price was at 378.37$.. Illumina does not by its reference above or distribution imply its endorsement of . Revenue is pegged at $1.05bn, up 46.8% from the $715.91m posted last year. Given the current short-term trend, the stock is expected to fall -18.23% during the next 3 months and, with a 90% probability hold a price between $269.25 and $329.99 at the end of this 3-month period. (NASDAQ: ILMN) Illumina's current Earnings Per Share (EPS) is $6.13. Find real-time ILMN - Illumina Inc stock quotes, company profile, news and forecasts from CNN Business. Earlier this year, Illumina fell over -30%, but then so did the entire market. Product revenues (84.4% of total revenues in 2020; down 6.6% from 2019) are primarily attributed to the partnerships and . Ten analysts forecast the average price in 12 months at $346.00 with a high forecast of $400.00 and a low forecast of $280.00. The bottom edge of the earnings outlook topped Illumina stock analysts' forecast for $5.56 per share. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. This is the main Illumina Inc stock chart and current price. Do you want to Buy Illumina Stocks ? Launched in 1998, Illumina works on a process called "genotyping," or comparing various DNA for insights. We think that Boston Scientific (NYSE:BSX) currently is a better pick compared to Illumina (NASDAQ:ILMN). Illumina's implied volatility exposes the market's sentiment of Illumina stock's possible movements over time. Webull offers kinds of Illumina, Inc. stock information, including NASDAQ:ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ILMN stock news, and many more online research tools to help you make informed decisions. Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved. Illumina (NASDAQ: ILMN) reported second-quarter results that beat Wall Street estimates and raised its financial forecast for the year. What is ILMN's Earnings Per Share (EPS) forecast for 2021-2023? By Larry Ramer, InvestorPlace Contributor . ; Illumina Inc has risen higher in 14 of those 21 years over the subsequent 52 week period, corresponding to a historical accuracy of 66.67 % ; Is Illumina Inc Stock Undervalued? The median estimate represents a +15.42% increase from the last price of 365.61. $366.67 -$10.48 -2.8%. It's trading around 8.9% below my intrinsic value, which means if you buy Illumina today, you'd be paying a reasonable price for it. ET View Interactive ILMN Charts. Its revenue was up 39.3% compared to the same quarter last year. Illumina generates revenue from two segments - Product and Service. The highest, average, and lowest price target of all analysts. Find the latest Illumina, Inc. (MYL) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Over the past year, the shares have gained 73%. Price target in 14 days: 421.480 EUR. Illumina is expected to post earnings of $1.14 a share in the third quarter, up from $1.02 a share in the same quarter last year. 22 July 2021 - EC opens up an in-depth investigation to determine " whether its initial competition concerns are confirmed.". With or without Grail, the longer-term outlook for ILMN stock is very bright. Illumina Inc's average analyst rating is Hold . Polen Capital, in its Q3 2021 investor letter, mentioned Illumina, Inc. (NASDAQ: ILMN) and discussed its stance on the firm.Illumina, Inc. is a San Diego, California-based biotechnology company . WOW Bionano Genomics Hires 2 Illumina Executives! The business earned $1.11 billion during the quarter, compared to analyst estimates of $1.04 billion. BNGO Stock ForecastWhat is your BNGO Stock Price Prediction and thoughts on This latest news with Bionano G. Better Bet Than ILMN Stock: Pay Less Than Illumina To Get More From S&P 500 Stocks ADBE, NFLX, AAPL, TMO, HD 2021-11-09 Better Bet Than ILMN Stock: Pay Less Than Illumina To Get More From Stocks INTU, DHR, TMO, LOW, INTC Illumina Inc (NASDAQ: ILMN) reported Q3 revenues of $1.11 billion, +40% Y/Y, beating the consensus of $1.04 billion. Complete Illumina Inc. stock information by Barron's. View real-time ILMN stock price and news, along with industry-best analysis. That rating is better than 55% of stocks based on data compiled by InvestorsObserver. Illumina Stock Forecast: As a breakout biotech stock, Illumina gets quite a bit of attention as investors look to benefit from some of the best groundbreaking new developments in genomics and DNA research.. Illumina is a big player in biotechnology. 2021-12-03 CALL at $275.0 Option on Illumina. This price target is based on 10 analysts offering 12 month price targets for Illumina in the last 3 months. Illumina is selling for 390.27 as of the 10th of November 2021. 2020 was a rough year for Illumina, but the stock price ended 2020 at $370.00 . The average price target is $435.18, with a high forecast of $570.00 and a low forecast of $335.00. About the Illumina, Inc. stock forecast. ILLUMINA Stock Forecast, ILU stock price prediction. Consolidated Product revenues were $978 million,. The Illumina stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Illumina stock analysts forecast $4.35 billion in full-year . Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Over the next 52 weeks, Illumina Inc has on average historically risen by 31.7 % based on the past 21 years of stock performance. We bring you the best guides about this stock with rates, background information, statistics, how to's and more. ILMN. The life sciences company reported $1.45 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.21. Stock Illumina Though recent news is positive, the growth forecast for 2020 isn't wowing investors, and the company's agreement with Roche, the launch of two new sequencing systems -- the . ILMN Stock Trend. Illumina, Inc. (NASDAQ: ILMN ) was in 51 hedge funds' portfolios at the . So is Illumina a buy? Analysts' call for $4.01 billion in sales would rise just 24%. Let's adjust this first: Illumina return adjusted by market return - ( -7.05 minus -2.45) = -4.6%. The revenue forecast for the quarter is 26% higher than last year's. For fiscal year 2021, Illumina now expects year-over-year revenue growth in the range of 25%-28% compared to fiscal year 2020. NasdaqGS:ILMN Debt to Equity History November 30th 2021. Analyst Forecast. Yesterday, Illumina stock fell just over -7% at market closing price.

Jon Gruden Contract Details Guaranteed Money, Boneshaker Transportation, Everton Player Investigated, Nasa Breaking News Today 2021, Best Country Clubs In Portland Oregon, Golfnow Customer Service,